Delivery Order SPE2DB22D1202-SPE2DB25FVAD6
Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,896.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injections (0.5 ml units) with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,758.57 firm fixed-price delivery order on August 14, 2025, for Mounjaro 2.5 mg/0.5 mL pen injections, with an ultimate completion date of August 15, 2025. The contract, issued without set-aside designation, represents a competitively awarded procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,028.73 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen injections on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $2,596.96 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injections on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,577.37 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a injectable medication used in diabetes management, and this order represents a routine...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside procurement and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,162.70 for Mounjaro 5 mg/0.5 mL pen injectors on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,325.40 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,405.86 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on August 7, 2025, with completion expected by August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes,...